🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Compared to placebo, treatment with ChAgly CD3 has a beneficial effect on p...
Status
Completed
Location
Universitair Ziekenhuis Antwerpen
Start Date
2000-06
Trial ID
NCT00627146
Treatments Being Tested
DEFEND-2 is a Phase 3 confirmatory study for the Phase 3 DEFEND-1 study. Th...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-17
Trial ID
NCT01123083
Treatments Being Tested
This study is a randomised, single-blind, placebo-controlled, repeat dose s...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-12
Trial ID
NCT01101555
Treatments Being Tested
The purpose of this study is to find out if an 8-day series of otelixizumab...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07-29
Trial ID
NCT00678886
The aim of this Phase I/IIa study is to identify a safe and tolerable dosag...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-12
Trial ID
NCT02000817
Treatments Being Tested
The purpose of this study is to investigate the safety and tolerability of ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01114503
This study will assess the subcutaneous administration of otelixizumab to T...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07-08
Trial ID
NCT00946257
Treatments Being Tested
The assessment of otelixizumab in rheumatoid arthritis subjects will provid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-04-28
Trial ID
NCT01077531
Treatments Being Tested
The purpose of this study to assess the safety and tolerability of re-dosin...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-11-22
Trial ID
NCT01222078
Treatments Being Tested
The purpose of this study is to optimize several multi-dose regimens of ote...
Status
Terminated
Location
GSK Investigational Site
Start Date
2006-07-31
Trial ID
NCT00451321
Treatments Being Tested